Cargando…
Acyclovir-induced neurotoxicity in an immunocompromised patient
This is a case report of a 75-year-old immunocompromised male who developed encephalopathy while undergoing treatment for disseminated herpes zoster with peripheral nerve involvement. While his initial presentation involved primarily profound lower extremity weakness, he developed progressive confus...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425261/ https://www.ncbi.nlm.nih.gov/pubmed/32850129 http://dx.doi.org/10.1177/2050313X20946518 |
_version_ | 1783570463095521280 |
---|---|
author | Marks, Daniel De La Paz, Andrew Walston, Bobbi Jo |
author_facet | Marks, Daniel De La Paz, Andrew Walston, Bobbi Jo |
author_sort | Marks, Daniel |
collection | PubMed |
description | This is a case report of a 75-year-old immunocompromised male who developed encephalopathy while undergoing treatment for disseminated herpes zoster with peripheral nerve involvement. While his initial presentation involved primarily profound lower extremity weakness, he developed progressive confusion to the point of obtundation only after initiation of standard therapy with intravenous acyclovir. The evaluation of his altered mental status was largely unremarkable. It was only after his acyclovir was discontinued that his symptoms resolved and he returned to his baseline mental status. His presentation was most consistent with acyclovir-induced neurotoxicity, which can present in patients with renal impairment and those who are immunocompromised. |
format | Online Article Text |
id | pubmed-7425261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-74252612020-08-25 Acyclovir-induced neurotoxicity in an immunocompromised patient Marks, Daniel De La Paz, Andrew Walston, Bobbi Jo SAGE Open Med Case Rep Case Report This is a case report of a 75-year-old immunocompromised male who developed encephalopathy while undergoing treatment for disseminated herpes zoster with peripheral nerve involvement. While his initial presentation involved primarily profound lower extremity weakness, he developed progressive confusion to the point of obtundation only after initiation of standard therapy with intravenous acyclovir. The evaluation of his altered mental status was largely unremarkable. It was only after his acyclovir was discontinued that his symptoms resolved and he returned to his baseline mental status. His presentation was most consistent with acyclovir-induced neurotoxicity, which can present in patients with renal impairment and those who are immunocompromised. SAGE Publications 2020-08-11 /pmc/articles/PMC7425261/ /pubmed/32850129 http://dx.doi.org/10.1177/2050313X20946518 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Marks, Daniel De La Paz, Andrew Walston, Bobbi Jo Acyclovir-induced neurotoxicity in an immunocompromised patient |
title | Acyclovir-induced neurotoxicity in an immunocompromised patient |
title_full | Acyclovir-induced neurotoxicity in an immunocompromised patient |
title_fullStr | Acyclovir-induced neurotoxicity in an immunocompromised patient |
title_full_unstemmed | Acyclovir-induced neurotoxicity in an immunocompromised patient |
title_short | Acyclovir-induced neurotoxicity in an immunocompromised patient |
title_sort | acyclovir-induced neurotoxicity in an immunocompromised patient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425261/ https://www.ncbi.nlm.nih.gov/pubmed/32850129 http://dx.doi.org/10.1177/2050313X20946518 |
work_keys_str_mv | AT marksdaniel acyclovirinducedneurotoxicityinanimmunocompromisedpatient AT delapazandrew acyclovirinducedneurotoxicityinanimmunocompromisedpatient AT walstonbobbijo acyclovirinducedneurotoxicityinanimmunocompromisedpatient |